Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01642121 · ClinicalTrials.gov registry record
Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia
A clinical trial of Childhood Acute Monoblastic Leukemia (M5a) and Childhood Acute Monocytic Leukemia (M5b), sponsored by Children's Oncology Group.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT01642121: Completed study of Childhood Acute Monoblastic Leukemia (M5a) and Childhood Acute Monocytic Leukemia (M5b), sponsored by Children's Oncology Group.
NCT01642121 is a study of Childhood Acute Monoblastic Leukemia (M5a) and Childhood Acute Monocytic Leukemia (M5b) that has completed, run by Children's Oncology Group. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01642121, a study of Childhood Acute Monoblastic Leukemia (M5a) and Childhood Acute Monocytic Leukemia (M5b), has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This laboratory study is looking into biomarkers in samples from younger patients with acute myeloid leukemia. Studying samples of bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
Conditions Studied
Interventions
- OTHER laboratory biomarker analysis
Study Locations (1)
California
- Children's Oncology Group - Monrovia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-08 |
What the finished NCT01642121 record still lists
NCT01642121 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 5 conditions, with Childhood Acute Monoblastic Leukemia (M5a) appearing as the primary indexed condition, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT01642121 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01642121 about?
NCT01642121 is a clinical study titled "Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia". This laboratory study is looking into biomarkers in samples from younger patients with acute myeloid leukemia. Studying samples of bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer
What is the current status of trial NCT01642121?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-08.
What conditions does trial NCT01642121 study?
This clinical trial studies the following conditions: Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies.
What interventions are being tested in trial NCT01642121?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT01642121?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01642121 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Acute Monoblastic Leukemia (M5a)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia